Literature DB >> 31000409

AAV Engineering Identifies a Species Barrier That Highlights a Portal to the Brain.

Luk H Vandenberghe1.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31000409      PMCID: PMC6520466          DOI: 10.1016/j.ymthe.2019.04.006

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  9 in total

1.  Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons.

Authors:  Sandra Duque; Béatrice Joussemet; Christel Riviere; Thibaut Marais; Laurence Dubreil; Anne-Marie Douar; John Fyfe; Philippe Moullier; Marie-Anne Colle; Martine Barkats
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

2.  The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice.

Authors:  Juliette Hordeaux; Qiang Wang; Nathan Katz; Elizabeth L Buza; Peter Bell; James M Wilson
Journal:  Mol Ther       Date:  2018-02-02       Impact factor: 11.454

3.  The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier.

Authors:  Juliette Hordeaux; Yuan Yuan; Peter M Clark; Qiang Wang; R Alexander Martino; Joshua J Sims; Peter Bell; Angela Raymond; William L Stanford; James M Wilson
Journal:  Mol Ther       Date:  2019-02-20       Impact factor: 11.454

4.  Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.

Authors:  Jerry R Mendell; Samiah Al-Zaidy; Richard Shell; W Dave Arnold; Louise R Rodino-Klapac; Thomas W Prior; Linda Lowes; Lindsay Alfano; Katherine Berry; Kathleen Church; John T Kissel; Sukumar Nagendran; James L'Italien; Douglas M Sproule; Courtney Wells; Jessica A Cardenas; Marjet D Heitzer; Allan Kaspar; Sarah Corcoran; Lyndsey Braun; Shibi Likhite; Carlos Miranda; Kathrin Meyer; K D Foust; Arthur H M Burghes; Brian K Kaspar
Journal:  N Engl J Med       Date:  2017-11-02       Impact factor: 91.245

5.  Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

Authors:  Kevin D Foust; Emily Nurre; Chrystal L Montgomery; Anna Hernandez; Curtis M Chan; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2008-12-21       Impact factor: 54.908

6.  Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders.

Authors:  Adam K Bevan; Sandra Duque; Kevin D Foust; Pablo R Morales; Lyndsey Braun; Leah Schmelzer; Curtis M Chan; Mary McCrate; Louis G Chicoine; Brian D Coley; Paul N Porensky; Stephen J Kolb; Jerry R Mendell; Arthur H M Burghes; Brian K Kaspar
Journal:  Mol Ther       Date:  2011-08-02       Impact factor: 11.454

7.  Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.

Authors:  Kevin D Foust; Xueyong Wang; Vicki L McGovern; Lyndsey Braun; Adam K Bevan; Amanda M Haidet; Thanh T Le; Pablo R Morales; Mark M Rich; Arthur H M Burghes; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2010-02-28       Impact factor: 68.164

8.  Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain.

Authors:  Benjamin E Deverman; Piers L Pravdo; Bryan P Simpson; Sripriya Ravindra Kumar; Ken Y Chan; Abhik Banerjee; Wei-Li Wu; Bin Yang; Nina Huber; Sergiu P Pasca; Viviana Gradinaru
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

9.  Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.

Authors:  Ken Y Chan; Min J Jang; Bryan B Yoo; Alon Greenbaum; Namita Ravi; Wei-Li Wu; Luis Sánchez-Guardado; Carlos Lois; Sarkis K Mazmanian; Benjamin E Deverman; Viviana Gradinaru
Journal:  Nat Neurosci       Date:  2017-06-26       Impact factor: 24.884

  9 in total
  1 in total

1.  Pre-arrayed Pan-AAV Peptide Display Libraries for Rapid Single-Round Screening.

Authors:  Kathleen Börner; Eike Kienle; Lin-Ya Huang; Jonas Weinmann; Anna Sacher; Philipp Bayer; Christian Stüllein; Julia Fakhiri; Laura Zimmermann; Adrian Westhaus; Jürgen Beneke; Nina Beil; Ellen Wiedtke; Carolin Schmelas; Dominik Miltner; Alexander Rau; Holger Erfle; Hans-Georg Kräusslich; Martin Müller; Mavis Agbandje-McKenna; Dirk Grimm
Journal:  Mol Ther       Date:  2020-02-13       Impact factor: 11.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.